Medicus Pharma Ltd (MDCX) Stock Price

1.46 ▼ -0.105 (-6.71%)
Open: 1.54 Vol: 289.1K Day's range: 1.45 - 1.58 Dec 29, 16:00 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
MDCX Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 1.55▼ 1.56▼ 1.55▼ 1.53▼ 1.73▼
MA10 1.55▼ 1.55▼ 1.55▼ 1.63▼ 2.00▼
MA20 1.57▼ 1.59▼ 1.60▼ 1.80▼ 2.20▼
MA50 1.63▼ 1.68▼ 1.75▼ 2.10▼ 2.94▼
MA100 1.67▼ 1.86▼ 1.89▼ 2.19▼ N/A    
MA200 1.86▼ 1.99▼ 2.09▼ 2.90▼ N/A    
  5 mins 30 mins Hourly Daily Weekly
MACD 0.000▼ 0.002▲ 0.006▲ -0.026▼ -0.070▼
RSI 41.283▼ 40.145▼ 38.896▼ 32.114▼ 36.146▼
STOCH 50.000     50.231     43.876     8.103▼ 17.095▼
WILL %R -88.889▼ -88.889▼ -95.455▼ -98.750▼ -99.248▼
CCI -108.957▼ -111.524▼ -99.418     -99.210     -156.687▼
Latest Filters Detected On MDCX
▼ BREAK $MDCX Price Breaks 60 Days Low Set Alert
▼ BREAK $MDCX Price Breaks 30 Days Low Set Alert
▼ BREAK $MDCX Price Breaks 20 Days Low Set Alert
▼ BREAK $MDCX Price Breaks 10 Days Low Set Alert
Medicus Pharma Ltd News
Medicus Pharma Ltd. Announces Engagement With Reliant AI to Develop Artificial Intelligence (AI) Driven Clinical Data Analytics Platform
Monday, December 22, 2025 02:35 AM
The engagement establishes a multi-phase framework to support AI enabled capital efficient development of Teverelix, a next generation GnRH antagonist, as a first in class market product for acute ...
Skunk Works® and XTEND Expand Joint All Domain Command and Control for Advanced Mission Execution
Thursday, December 18, 2025 02:59 AM
Skunk Works® and XTEND collaborated to integrate the XTEND Operating System (XOS) into Skunk Works' MDCX™ autonomy platform, allowing simultaneous Command and Control (C2) of multiple classes of UAS, ...
Medicus Pharma Ltd. Completes Enrolment of Ninety (90) Patients for Phase 2 Clinical Study (SKNJCT-003) to Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin
Monday, December 15, 2025 04:46 AM
THE COMPANY EXPECTS TO RELEASE TOPLINE RESULTS FOR SKNJCT-003 PHASE 2 CLINICAL TRIAL BEFORE THE END OF Q1 2026 AND REQUEST END-OF-PHASE 2 (EOP2) WITH THE FOOD AND DRUG ADMINISTRATION (FDA) IN H1 2026 ...
MDCX historical stock data
date open high low close volume
29/12/25 1.54 1.58 1.45 1.46 289,100
26/12/25 1.57 1.60 1.53 1.565 246,500
24/12/25 1.52 1.60 1.51 1.55 284,600
23/12/25 1.57 1.61 1.49 1.52 330,862
22/12/25 1.73 1.74 1.55 1.56 467,700
19/12/25 1.62 1.74 1.59 1.69 339,900
18/12/25 1.75 1.7508 1.60 1.66 268,667
17/12/25 1.86 1.89 1.68 1.69 333,500
16/12/25 1.89 1.94 1.77 1.80 334,100
15/12/25 1.975 2.0317 1.81 1.83 398,050
Quote Details
52wk Low:1.45
52wk High:8.901
Vol:289.1K
Avg Vol(3m):6.7M
1Y Chng:-44.70%
1M Chng:-33.64%
Add to Watch List
More Information
Index US Composite
Market Cap. 38.67M